Gossamer Bio goes public; San Diego biotech valued at more than $1 billion

Gossamer Bio became San Diego’s newest publicly traded company this week, bringing in a hefty haul of $276 million in its initial public offering. The offering indicated that the bull market for biotech, prevalent during last year, continues.

The biotech company is led by veterans of multiple sclerosis…

Click to view original post